With no prospect in sight of a cure for degenerative joint disease, there is huge and increasing demand for surgical treatment. Life expectancy is increasing and also the level of activity of older patients is increasing. The knee is arguably the most vulnerable joint in the body and certainly the most frequently injured. More knees are now being replaced than hips, the most recent (6th) National Joint Registry (NJR) Annual Report records 75,629 knee and 71,367 hip procedures.1 In the US, the projected demand change for knee replacement by 2030 is estimated at 673%.2 There is no reason to suspect that England and Wales will be any different which means approximately 500,000 per annum or 1000 every morning and afternoon 5 days a week, 50 weeks a year!
Clearly, also, it is important that we get it right. There has been increasing interest over the last few years in unicompartmental knee replacement (UKR) as against total knee replacement (TKR) for osteoarthritis localised to one compartment of the knee. TKR is not a strictly correct term as not all surgeons resurface the patella. There is possibly a certain logic in only replacing diseased tissue. The medial compartment is most commonly the site of isolated replacement, the patellofemoral compartment less so and the lateral compartment rarely. Enthusiasts for UKR quote such advantages as shorter hospital stay, quicker recovery and better function. The main drawback is, of course, progression of the degenerative joint disease in the other compartments necessitating revision surgery.
Is TKR a reliable procedure? The answer is a definite yes. There are a number of reports now of the long-term success with very recently a 98% implant survival at 20 years.3 Can UKR do better than this? There is no proof that it can. Indeed there are concerns regarding an increased failure rate. The 6th NJR Annual Report shows patients who had a UKR to have the highest revision rate with UKR 7.2% and patellofemoral 8.3% at 3 years against 1.7% receiving a PFC Sigma, the most commonly used TKR.1 In an NJR-based review of 80,697 patients undergoing primary knee replacement between 2003 and 2006, again the revision rate was highest in those receiving a UKR (2.8% at 3 years against 1.4% receiving a cemented TKR).4 The revision rate did not decrease with time suggesting the problem is related to the implant rather than the surgeon on a ‘learning curve’. Moreover, in a sample of 10,000 patients from the NJR in 2003, UKR patients were less likely to be satisfied with their joint replacement than patients with a cemented TKR.5
This is an international, not just a national, trend. The Australian Joint Registry (209,316 knee procedures registered since 1999) 2008 report states that UKR has continued to decrease in use for a number of years, and that there is approximately twice the revision rate of TKR at any age.6 The Australian database of over 1000 patellofemoral UKRs shows a revision rate of 13.8% at 5 years. From Finland, Koskinen et al.7 reported 1886 primary UKRs and 48,607 primary TKRs from the National Joint Registry, 1980 to 2003 inclusive. UKRs had a survival rate at 15 years of 60% and TKRs 80%. There was no cost benefit with UKR, in fact the reverse. Again, results of UKR did not improve over time. In Sweden, over 30 years of Joint Registry experience shows that UKR has a substantially higher cumulative revision rate than TKR.8 Around the world this is a massive experience.
Notwithstanding these figures, is there logic behind limited anatomical replacement for what is by nature a progressive disease? Over the years there has been considerable debate regarding the indications for UKR particularly with respect to the degree of disease that is acceptable in the other compartments. There is a school of thought that believes isolated medial unicompartmental replacement can be carried out even in the presence of quite significant patellofemoral disease.9,10 The fact that isolated patellofemoral arthroplasty is a well-recognised procedure, however, means that many surgeons believe that patellofemoral disease warrants replacement in its own right. They cannot both be right or to quote Dire Straits ‘Two men say they’re Jesus one of them must be wrong’.11 Maybe they are both wrong? Maybe all knee replacements should be total!
References
-
1.National Joint Registry for England and Wales. National Joint Registry for England and Wales 6th Annual Report 2009. http://www.njr.centre.org.uk [accessed 19 September 2009]
-
2.Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785. doi: 10.2106/JBJS.F.00222. [DOI] [PubMed] [Google Scholar]
-
3.Ritter MA. The anatomical graduated component total knee replacement: a long-term evaluation with 20-year survival analysis. J Bone Joint Surg Br. 2009;91:745–749. doi: 10.1302/0301-620X.91B6.21854. [DOI] [PubMed] [Google Scholar]
-
4.Sibanda N, Copley LP, Lewsey JD, Borroff M, Gregg P, MacGregor AJ, et al. Revision rates after primary hip and knee replacement in England between 2003 and 2006. Plos Med. 2008;5:e179. doi: 10.1371/journal.pmed.0050179. [DOI] [PMC free article] [PubMed] [Google Scholar]
-
5.Baker PN, van der Meulen JH, Lewsey J, Gregg PJ. The role of pain and function in determining patient satisfaction after total knee replacement: data from the National Joint Registry for England and Wales. J Bone Joint Surg Br. 2007;89:893–900. doi: 10.1302/0301-620X.89B7.19091. [DOI] [PubMed] [Google Scholar]
-
6.Australian Orthopaedic Association. Australian Orthopaedic Association National Joint Replacement Registry, Annual Report 2008. http://www.dmac.adelaide.edu.au/aoanjrr/documents/aoanjrrreport_2008.pdf [accessed 19 September 2009]
-
7.Koskinen E, Eskelinen A, Paavolainen P, Pulkkinen P, Remes V. Comparison of survival and cost effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: a follow-up study of 50,493 knee replacements from the Finnish Arthroplasty Register. Acta Orthop. 2008;79:499–507. doi: 10.1080/17453670710015490. [DOI] [PubMed] [Google Scholar]
-
8.Swedish Orthopaedic Association. The Swedish Knee Arthroplasty Register Annual Report 2008. www.knee.nko.se/english/online/uploadedFiles/112_SVK_2008Engl_1.1.pdf [accessed 19 September 2009]
-
9.Beard DJ, Pandit H, Gill HS, Hollinghurst D, Dodd CAF, Murray DW. The influence of the presence and severity of pre-existing patellofemoral degenerative changes on the outcome of the Oxford medial unicompartmental knee replacement. J Bone Joint Surg Br. 2007;89:1597–1601. doi: 10.1302/0301-620X.89B12.19259. [DOI] [PubMed] [Google Scholar]
-
10.Beard DJ, Pandit H, Ostlere S, Jenkins C, Dodd CAF, Murray SW. Pre-operative clinical and radiological assessment of the patellofemoral joint in unicompartmental knee replacement and its influence on outcome. J Bone Joint Surg Br. 2007;89:1602–1607. doi: 10.1302/0301-620X.89B12.19260. [DOI] [PubMed] [Google Scholar]
-
11.Dire Straits. Industrial Disease. In: Love Over Gold. London: Phonogram Ltd, 1982.